EXOBIOSPHERE, INC. — National Aeronautics and Space Administration STTR Phase I: COMPLEX ORGANOID SCREENING IN MICROGRAVITY FOR INTRACTABLE CANCERS
EXOBIOSPHERE, INC. — STTR Phase I award from National Aeronautics and Space Administration.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from National Aeronautics and Space Administration in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $224,161. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Space & Satellite, Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Exobiosphere, Inc. received a NASA STTR Phase I award of $224,161 to study complex organoid screening in microgravity for hard-to-treat cancers. The work uses space conditions to advance new insights into cancer treatments.
- Amount
- $224,161
- Agency
- National Aeronautics and Space Administration · National Aeronautics and Space Administration
- Program / Phase
- STTR · Phase I
- NAICS
- 541713 · RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY
- Place of performance
- DE
- Period
- 2026-09-30 → 2027-10-29
Technology domains
Description
STTR PHASE I COMPLEX ORGANOID SCREENING IN MICROGRAVITY FOR INTRACTABLE CANCERS